Publications in collaboration with researchers from Hospital Xeral Calde (24)

2018

  1. Real world patient-reported outcomes in HIV-infected adults switching to EVIPLERA®, because of a previous intolerance to cART. PRO-STR study

    Current HIV Research, Vol. 16, Núm. 6, pp. 425-435

2016

  1. Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: Estimates and risk factors

    AIDS, Vol. 30, Núm. 1, pp. 37-44

2010

  1. El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infeccin por VIH-1

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 9, pp. 615-620

  2. Liver toxicity after switching or simplifying to nevirapine-based therapy is not related to cd4 cell counts: Results of the TOSCANA study

    HIV Clinical Trials, Vol. 11, Núm. 1, pp. 11-17

  3. Short communication: Biological and genetic characterization of HIV type 1 subtype B and nonsubtype B transmitted viruses: Usefulness for vaccine candidate assessment

    AIDS Research and Human Retroviruses, Vol. 26, Núm. 9, pp. 1019-1025

2009

  1. (Enfermedades Infecciosas y Microbiologia Clinica (2009) 27, 4, (222-235))

    Enfermedades Infecciosas y Microbiologia Clinica

  2. HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations

    Journal of Antimicrobial Chemotherapy, Vol. 64, Núm. 2, pp. 251-258

  3. The Spanish HIV BioBank: A model of cooperative HIV research

    Retrovirology, Vol. 6

  4. The changing face of HIV/AIDS in treated patients

    Current HIV Research, Vol. 7, Núm. 4, pp. 365-377

2008

  1. Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients

    Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 1, pp. 206-209

2007

  1. Cost minimization analysis of the different combinations of nucleoside analog reverse transcriptase inhibitors associated with adverse events in HIV-1 infected patients

    Pharmacoeconomics - Spanish Research Articles, Vol. 4, Núm. 1, pp. 25-36

  2. Report from the 9th International Workshop on adverse drug reactions and lipodystrophy in HIV

    Nutrition and Metabolic Disorders in HIV Infection

  3. Summary of the 4th International AIDS Society Conference on HIV pathogenesis, treatment, and prevention

    Nutrition and Metabolic Disorders in HIV Infection

  4. Tratamiento quirúrgico de la lipodistrofia asociada a la infección por VIH. Conclusiones de una reunión multidisciplinar

    Enfermedades Infecciosas y Microbiologia Clinica

2006

  1. Isolation and biological characterization of HIV-1 BG intersubtype recombinants and other genetic forms circulating in Galicia, Spain

    Journal of Medical Virology, Vol. 78, Núm. 12, pp. 1520-1528

  2. Summary of the 13th Conference on Retroviruses and Opportunistic Infections. February 5-8, 2006. Colorado Convention Center. Denver, CO, USA

    Nutrition and Metabolic Disorders in HIV Infection

  3. Summary of the 8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. 24-26 September 2006, San Francisco,CA, USA

    Nutrition and Metabolic Disorders in HIV Infection

  4. Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir

    AIDS, Vol. 20, Núm. 10, pp. 1407-1414

2005

  1. Antiretroviral treatment simplification with 3 NRTIs or 2 NRTIs plus nevirapine in HIV-1-infected patients treated with successful first-line HAART

    Journal of Acquired Immune Deficiency Syndromes, Vol. 39, Núm. 3, pp. 313-316

  2. Antiretroviral treatment. Should it be different than in males?

    Nutrition and Metabolic Disorders in HIV Infection